[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368093-105":59,"doc-detail-368093-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","screening-the-advantageous-population-for-liver-cancer-undergoing-yttrium-90-microsphere-selective-internal-radiation-therapy","Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy","","Yttrium-90 microsphere selective internal radiation therapy (SIRT), also known as transarterial radioembolization, is a key treatment for liver cancer in selected advantageous patient groups. This review characterizes different patient profiles that may derive the greatest benefit from SIRT and examines major determinants of efficacy and safety, including tumor features, liver function, performance status, and treatment intent. Candidate evaluation relies on mapping to simulate tumor vascular anatomy, predict lung shunting, and support catheter positioning and dose planning, improving therapeutic precision while reducing nontarget radiation-related adverse events. The review summarizes evidence for use in early or limited hepatocellular carcinoma, and for bridging therapy to transplantation, conversion therapy for unresectable disease, and combination approaches with systemic treatments to improve survival. It also emphasizes ongoing optimization through personalized dosimetry and mapping to ensure precision and safety, grounded in literature and clinical practice.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/screening-the-advantageous-population-for-liver-cancer-undergoing-yttrium-90-microsphere-selective-internal-radiation-therapy/368093/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/screening-the-advantageous-population-for-liver-cancer-undergoing-yttrium-90-microsphere-selective-internal-radiation-therapy/368093.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SIRT and how does it work for liver cancer?","Question",{"text":112,"@type":113},"SIRT delivers millions of yttrium-90 loaded microspheres via minimally invasive hepatic arterial access to the tumor-feeding branches. The emitted beta radiation targets tumor tissue while limiting exposure to surrounding normal liver tissue.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is mapping important when selecting candidates for SIRT?",{"text":117,"@type":113},"Mapping simulates tumor vascular anatomy, predicts lung shunting, and guides catheter positioning and dose planning. It helps increase therapeutic precision and reduce risks of nontarget radiation-related adverse events such as pneumonitis and gastrointestinal toxicity.",{"name":119,"@type":110,"acceptedAnswer":120},"Which patient groups may benefit the most from SIRT?",{"text":121,"@type":113},"The review focuses on the advantageous population that could gain maximum benefit, including patients with early or limited hepatocellular carcinoma, and those who may receive SIRT as bridging therapy, conversion therapy for unresectable disease, or in combination with systemic treatments for improved outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368093,1791008528,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Liver Research 10 (2026) 61–70  \nContents lists available at ScienceDirect  \nLiver Research  \njournal homepage: [http://www . keaipublishing . com/en/journals/liver-research](http://www . keaipublishing . com/en/journals/liver-research)  \n| Review Article |  |  |\n| --- | --- | --- |\n| Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy |  | |\n| Licong Liang a, b, Yuchan Liang a, b, Wensou Huang a, b, Yongjian Guo a, b, Jingjun Huang a, b, Jingwen Zhou a, b, Liteng Lin a, b, Xinxin Nie c, Mingyue Cai a, b, Kangshun Zhu a, b, *\u003Cbr>a Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China\u003Cbr>b Guangdong Engineering Technology Research Center of Interventional Oncology and Precision Drug Delivery, Guangzhou, Guangdong, China c College of Basic Medical Science, China Three Gorges University, Yichang, Hubei, China |  |  |\n| a r t i c l e i n f o | a b s t r a c t\u003Cbr>Yttrium-90 microsphere selective internal radiation therapy (SIRT), also known as transarterial radioembolization, has become one of the pivotal treatments for liver cancer, particularly for selected advantageous patient groups. This review summarizes the characteristics of different patients with liver cancer that could obtain maximum benefit from SIRT and discusses key factors affecting efficacy and safety, including tumor characteristics, liver function, patient performance status, and treatment intent. In evaluating appropriate candidates, mapping serves as a crucial simulation procedure to assess tumor vascular anatomy, predict lung shunting, and guide catheter positioning and dose planning. This procedure substantially enhances therapeutic precision while minimizing the risk of nontarget radiationrelated adverse events, such as radiation-induced pneumonitis and gastrointestinal toxicity. Several studies have suggested that SIRT is not only suitable for patients with early or limited hepatocellular carcinoma but can also be used as a bridging therapy for liver transplantation and conversion therapy for unresectable liver cancers. In combination with systemic treatments, SIRT has demonstrated survival benefits in patients with unresectable liver cancer. This review also highlights the importance of further optimizing patient screening through personalized dosimetry and mapping to ensure the precision and safety of treatment. A thorough review of relevant literature and clinical practice offers clinicians comprehensive suggestions on patient screening and clarifies the promise of SIRT in the liver cancer population.\u003Cbr>© 2025 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)). |  |\n| Article history:\u003Cbr>Received 2 November 2024 Received in revised form\u003Cbr>6 December 2025\u003Cbr>Accepted 9 December 2025 |  |  |\n| Keywords:\u003Cbr>Liver cancer\u003Cbr>Selective internal radiation therapy (SIRT) Transarterial radioembolization (TARE) Yttrium-90\u003Cbr>Advantageous population |  |  |\n\n1. Introduction  \nLiver cancer has seriously affected the lifespan of millions of people worldwide and remains a global health challenge. As highdose external radiation results in radiation-induced liver injury through DNA and/or mitochondrial damage, complications may include hepatitis, fibrosis, cirrhosis, and canceration, which have greatly limited the use of high-dose radiotherapy in liver cancer treatment.1 However, selective internal radiation therapy (SIRT)  \n* Corresponding author. Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.  \nE-mail address: [zhksh010@163.com](zhksh010@163.com) (Ka","cbCaisULsj8E09wU","https://ap.wps.com/l/cbCaisULsj8E09wU","pdf",2519400,"English","# Article information\n## Abstract and keywords\n## Article history\n# Introduction\n## Background on liver cancer and radiation injury\n## Development and rationale of SIRT (90Y-TARE/Y90-RE)\n## Evolution of indications and the need for screening","[{\"question\":\"What is SIRT and how does it work for liver cancer?\",\"answer\":\"SIRT delivers millions of yttrium-90 loaded microspheres via minimally invasive hepatic arterial access to the tumor-feeding branches. The emitted beta radiation targets tumor tissue while limiting exposure to surrounding normal liver tissue.\"},{\"question\":\"Why is mapping important when selecting candidates for SIRT?\",\"answer\":\"Mapping simulates tumor vascular anatomy, predicts lung shunting, and guides catheter positioning and dose planning. It helps increase therapeutic precision and reduce risks of nontarget radiation-related adverse events such as pneumonitis and gastrointestinal toxicity.\"},{\"question\":\"Which patient groups may benefit the most from SIRT?\",\"answer\":\"The review focuses on the advantageous population that could gain maximum benefit, including patients with early or limited hepatocellular carcinoma, and those who may receive SIRT as bridging therapy, conversion therapy for unresectable disease, or in combination with systemic treatments for improved outcomes.\"}]","Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy | PDF",1790174985,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16255617a4ba14294982b2715146e964.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4902bf20aded595cd840e77edd7f7f1e.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0dbc29e0cc6b4e56fe759121f3523ea.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c087077ec890c78a7449a2d774d48afa.webp",980,1306]